IL-1 Signal Inhibition in Alcoholic Hepatitis

Clinical trial NCT03775109 · COMPLETED

Trial details

NCT number: NCT03775109
Sponsor: Imperial College London
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alcoholic Hepatitis

Start date: 2019-02-12
Primary completion: 2023-03-31
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.